Intervention results in increased use of evidence-based medications for patients with acute coronary syndrome

March 25, 2012

Among patients with acute coronary syndromes (such as heart attack or unstable angina) treated at public hospitals in Brazil, implementation of a multifaceted intervention that included educational materials, checklists and reminders resulted in improvement in the use of evidence-based medicines during the first 24 hours of hospitalization, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the American College of Cardiology's annual scientific sessions.

Cardiovascular diseases, especially acute coronary syndromes (ACS), are the leading cause of illness and death globally. Large-scale randomized trials have established the efficacy of several interventions for the care of with ACS; nevertheless, registries have consistently demonstrated that the translation of into practice is suboptimal and that these care gaps are even greater in low- and middle-income countries, according to background information in the article.

"Changing clinical behavior to improve quality of care is challenging. Prior systematic reviews have suggested that certain quality improvement (QI) tools are associated with better quality of care," the authors write. "However, QI interventions have rarely been rigorously evaluated, especially in low- and middle-income countries, which account for up to 80 percent of the global burden of cardiovascular diseases."

Otávio Berwanger, M.D., Ph.D., of the Research Institute HCor– do Coração, São Paulo, Brazil and colleagues conducted a randomized trial (Brazilian to Increase Evidence Usage in ; BRIDGE-ACS) to assess the effectiveness of a QI initiative in patients with ACS from in an emerging economy setting. The trial was conducted among 34 clusters (public hospitals) in Brazil and enrolled a total of 1,150 patients with ACS from March 2011 through November 2011, with follow-up through January 27, 2012. The multifaceted QI intervention included for clinicians, reminders, checklists, and case manager training, vs. routine practice (control). Among the outcomes measured by the researchers was the percentage of eligible patients who received all evidence-based therapies (aspirin, clopidogrel, anticoagulation, and statins) during the first 24 hours in patients without contraindications. The average age of the patients enrolled was 62 years; 69 percent were men.

The researchers found that among eligible patients (923/1,150 [80.3 percent]), those in intervention cluster hospitals were more likely to receive all eligible acute therapies within the first 24 hours than those in control cluster hospitals (67.9 percent vs. 49.5 percent). Similarly, use of all evidence-based therapies during the first 24 hours and at discharge among eligible patients (801/1,150 [69.7 percent]) was higher in the intervention clusters vs. controls (50.9 percent vs. 31.9 percent). Overall composite adherence scores were also higher in QI intervention clusters than in control group clusters (89 percent vs. 81.4 percent).

Regarding the effect of the intervention on major clinical events at discharge, the rates of major cardiovascular events were 5.5 percent for patients from clusters randomized to the QI intervention and 7.0 percent in control group clusters, without a statistical significant difference. Total mortality rates at 30 days were 7.0 percent in patients from clusters randomized to the QI intervention and 8.4 percent in patients from control group clusters.

"In conclusion, among patients with ACS, a simple multifaceted educational intervention resulted in significant improvement in the use of evidence-based medications, particularly in hospitals with percutaneous coronary intervention [procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries] capabilities and among patients with non–ST-segment elevation [a certain pattern on an electrocardiogram] ACS. Because this intervention is relatively simple and feasible, the approaches tested in the BRIDGE-ACS trial can become the basis for developing QI programs to maximize the use of evidence-based interventions for the management of ACS, especially in limited-resource settings. Large-scale international cluster-randomized trials with adequate power are warranted to assess the effect of QI interventions on clinical outcomes as well as on cost-effectiveness," the authors write.

Explore further: Studies evaluate programs to transition care of patients after hospital discharge

More information: JAMA. 2012;307(19):doi:10.1001/jama.2012.413

Related Stories

Studies evaluate programs to transition care of patients after hospital discharge

July 25, 2011
Programs designed to help transition care for hospitalized older patients to outside healthcare clinicians and settings are associated with reduced rates of hospital readmissions, according to two reports in the July 25 issue ...

Increase in evidence-based treatments followed by decreased risk of death in heart attack patients

April 26, 2011
In an analysis of data from a coronary care registry in Sweden, between 1996-2007 there was an increase in the prevalence of use of evidence-based invasive procedures and pharmacological therapies for treatment of a certain ...

Use of telephone intervention did not improve adherence to osteoporosis medication regimen

February 27, 2012
Telephone motivational counseling sessions did not result in a statistically significant improvement in adherence to an osteoporosis medication regimen, according to a report published Online First by Archives of Internal ...

Recommended for you

Low-salt and heart-healthy dash diet as effective as drugs for some adults with high blood pressure

November 22, 2017
A study of more than 400 adults with prehypertension, or stage 1 high blood pressure, found that combining a low-salt diet with the heart-healthy DASH diet substantially lowers systolic blood pressure—the top number in ...

Stroke patients may have more time to get treatment, study finds

November 22, 2017
Patients and doctors long have relied on a simple rule of thumb for seeking care after an ischemic stroke: "Time is brain."

Cases of heart failure continue to rise; poorest people worst affected

November 22, 2017
The number of people being diagnosed with heart failure in the UK continues to rise as a result of demographic changes common to many developed countries, new research by The George Institute for Global Health at the University ...

Some cancer therapies may provide a new way to treat high blood pressure

November 20, 2017
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer a real advance in hypertension treatment ...

Could this protein protect people against coronary artery disease?

November 17, 2017
The buildup of plaque in the heart's arteries is an unfortunate part of aging. But by studying the genetic makeup of people who maintain clear arteries into old age, researchers led by UNC's Jonathan Schisler, PhD, have identified ...

Raising 'good' cholesterol fails to protect against heart disease

November 16, 2017
Raising so-called 'good' cholesterol by blocking a key protein involved in its metabolism does not protect against heart disease or stroke, according to a large genetic study of 150,000 Chinese adults published in the journal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.